Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Holger Lenz is active.

Publication


Featured researches published by Holger Lenz.


Journal of Biological Chemistry | 2007

Vimentin Is the Specific Target in Skin Glycation STRUCTURAL PREREQUISITES, FUNCTIONAL CONSEQUENCES, AND ROLE IN SKIN AGING

Thomas Kueper; Tilman Grune; Stefanie Prahl; Holger Lenz; Vivienne Welge; Tanja Biernoth; Yvonne Vogt; Gesa Muhr; Astrid Gaemlich; Tobias Jung; Gerrit Boemke; Hans-Peter Elsässer; Klaus-Peter Wittern; Horst Wenck; Franz Stäb; Thomas Blatt

Until now, the glycation reaction was considered to be a nonspecific reaction between reducing sugars and amino groups of random proteins. We were able to identify the intermediate filament vimentin as the major target for the AGE modification Nϵ-(carboxymethyl)lysine (CML) in primary human fibroblasts. This glycation of vimentin is neither based on a slow turnover of this protein nor on an extremely high intracellular expression level, but remarkably it is based on structural properties of this protein. Glycation of vimentin was predominantly detected at lysine residues located at the linker regions using nanoLC-ESI-MS/MS. This modification results in a rigorous redistribution of vimentin into a perinuclear aggregate, which is accompanied by the loss of contractile capacity of human skin fibroblasts. CML-induced rearrangement of vimentin was identified as an aggresome. This is the first evidence that CML-vimentin represents a damaged protein inside the aggresome, linking the glycation reaction directly to aggresome formation. Strikingly, we were able to prove that the accumulation of modified vimentin can be found in skin fibroblasts of elderly donors in vivo, bringing AGE modifications in human tissues such as skin into strong relationship with loss of organ contractile functions.


Molecular and Cellular Biochemistry | 2007

Inhibition of cytosolic and mitochondrial creatine kinase by siRNA in HaCaT- and HeLaS3-cells affects cell viability and mitochondrial morphology

Holger Lenz; Melanie Schmidt; Vivienne Welge; Thomas Kueper; Uwe Schlattner; Theo Wallimann; Hans-Peter Elsässer; Klaus-Peter Wittern; Horst Wenck; Franz Staeb; Thomas Blatt

The creatine kinase (CK) system is essential for cellular energetics in tissues or cells with high and fluctuating energy requirements. Creatine itself is known to protect cells from stress-induced injury. By using an siRNA approach to silence the CK isoenzymes in human keratinocyte HaCaT cells, expressing low levels of cytoplasmic CK and high levels of mitochondrial CK, as well as HeLa cancer cells, expressing high levels of cytoplasmic CK and low levels of mitochondrial CK, we successfully lowered the respective CK expression levels and studied the effects of either abolishing cytosolic brain-type BB-CK or ubiquitous mitochondrial uMi-CK in these cells. In both cell lines, targeting the dominant CK isoform by the respective siRNAs had the strongest effect on overall CK activity. However, irrespective of the expression level in both cell lines, inhibition of the mitochondrial CK isoform generally caused the strongest decline in cell viability and cell proliferation. These findings are congruent with electron microscopic data showing substantial alteration of mitochondrial morphology as well as mitochondrial membrane topology after targeting uMi-CK in both cell lines. Only for the rate of apoptosis, it was the least expressed CK present in each of the cell lines whose inhibition led to the highest proportion of apoptotic cells, i.e., downregulation of uMi-CK in case of HeLaS3 and BB-CK in case of HaCaT cells. We conclude from these data that a major phenotype is linked to reduction of mitochondrial CK alone or in combination with cytosolic CK, and that this effect is independent of the relative expression levels of Mi-CK in the cell type considered. The mitochondrial CK isoform appears to play the most crucial role in maintaining cell viability by stabilizing contact sites between inner and outer mitochondrial membranes and maintaining local metabolite channeling, thus avoiding transition pore opening which eventually results in activation of caspase cell-death pathways.


Journal of Cosmetic Dermatology | 2008

A novel treatment option for photoaged skin

Anja Knott; Urte Koop; Heiko Mielke; Katja Reuschlein; Nils Peters; Gesa-Meike Muhr; Holger Lenz; Ursula Wensorra; Sören Jaspers; Ludger Kolbe; Thomas Raschke; Franz Stäb; Horst Wenck; Stefan Gallinat

Background  DNA damage as a result of ultraviolet (UV) exposure plays an important role in the progression of cutaneous aging. Both folic acid and creatine have been linked to the process of DNA protection and repair.


Annals of the New York Academy of Sciences | 2008

Modification of Vimentin

Thomas Kueper; Tilman Grune; Gesa-Meike Muhr; Holger Lenz; Klaus-Peter Wittern; Horst Wenck; Franz Stäb; Thomas Blatt

In a recent study, we were able to show that the intermediate filament protein vimentin aggregates in human dermal fibroblasts because of modification by the advanced glycation endproduct carboxymethyllysine (CML). In this work, we investigated the formation of intracellular CML in relation to the concentration of glucose in the culture medium. The natural degradation product of glucose, methylglyoxal, was able to induce the aggregation of vimentin. This dicarbonyl leads to the formation of the modifications MG‐H1 and carboxyethyllysine (CEL) as a result of the reaction with arginine and lysine residues of proteins. Furthermore, we found that the protein vimentin was modified, not only by CML and CEL, but also by pentosidine and pyrraline. These findings underline the special position of vimentin as a preferential target of the Maillard reaction in human skin.


Journal of Investigative Dermatology | 2005

The creatine kinase system in human skin: Protective effects of creatine against oxidative and UV damage in vitro and in vivo

Holger Lenz; Melanie Schmidt; Vivienne Welge; Uwe Schlattner; Theo Wallimann; Hans-Peter Elsässer; Klaus-Peter Wittern; Horst Wenck; Franz Stäb; Thomas Blatt


Biofactors | 2005

Stimulation of skin's energy metabolism provides multiple benefits for mature human skin

Thomas Blatt; Holger Lenz; Urte Koop; Sören Jaspers; T. Weber; Christopher Mummert; Klaus-Peter Wittern; Franz Stäb; Horst Wenck


Archive | 2005

Cosmetic or dermatological preparation with a content of creatine, creatinine or derivatives thereof in combination with soybean germ extract

Franz Stäb; Thomas Blatt; Melanie Schmidt; Claudia Mundt; Stefan Gallinat; Kirsten Venzke; Holger Lenz; Cornelia Meier-Zimmerer


Archive | 2004

Cosmetic or dermatological preparations including creatinine or a derivative thereof and creatine or a derivative thereof and methods of applying the preparations to the skin

Helga Biergiesser; Thomas Blatt; Inge Kruse; Holger Lenz; Claudia Mundt; Melanie Schmidt; Volker Schreiner; Uwe Dr. Schönrock; Franz Stäb


Archive | 2001

Cosmetic or dermatological preparations containing creatinine and creatine, useful e.g. for combating skin aging symptoms or treating inflammatory conditions such as eczema or psoriasis

Thomas Blatt; Helga Biergiesser; Uwe Schoenrock; Franz Staeb; Inge Kruse; Melanie Schmidt; Claudia Mundt; Holger Lenz; Volker Schreiner


Archive | 2004

Cosmetic or dermatological preparations containing creatine, creatinine and/or the derivatives thereof combined with soya bean extracts

Franz Staeb; Thomas Blatt; Melanie Schmidt; Claudia Mundt; Stefan Gallinat; Kirsten Venzke; Holger Lenz; Cornelia Meier-Zimmerer

Collaboration


Dive into the Holger Lenz's collaboration.

Researchain Logo
Decentralizing Knowledge